FAP and coronary artery disorder: By targeting FAP, CAR‐T cells can be used in the clinical treatment of myocardial fibrosis in patients with ischemic heart disease and improve ventricular remodelling, which will undoubtedly provide more comprehensive understanding and strategies for the treatment of cardiovascular diseases.